DIMENSIONAL FUND ADVISORS LP
Position in ATNM — Actinium Pharmaceuticals, Inc.
CIK 354204
AUSTIN, TX
Position in ATNM
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$34,748
-$12,747 QoQ
Shares Held
34,923
0.0% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 39%
Shared 26%
None 35%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. ATNM ranks #215 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in ATNM
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,748 | 34,923 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $47,495 | 34,923 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $55,876 | 34,923 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $48,891 | 34,923 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $56,225 | 34,923 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $44,002 | 34,923 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $96,412 | 51,284 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $827,829 | 111,869 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,131,160 | 144,465 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $748,979 | 147,437 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $963,591 | 162,769 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,336,674 | 180,145 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,705,705 | 180,498 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,745,746 | 163,920 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $867,267 | 117,516 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $131,332 | 27,304 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $139,523 | 27,304 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $156,915 | 26,109 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $98,159 | 11,079 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||